ホワイトペーパー「生物学的製剤の台頭 - 新たなトレンドと機会」をダウンロードいただき、ありがとうございます
ホワイトペーパーをお客様のメールアドレスに送信しました。届かない場合は、下のボタンをクリックすれば直接ダウンロードできます。
詳細については、CAS Custom Services℠をご覧ください。
Latest from CAS Insights™
創薬
How AI-driven analysis can accelerate drug discovery
Spiro[2.3]hexanes are an example of promising yet challenging scaffold structures for new drug compounds. By using AI-powered predictive analytics with CAS BioFinder, researchers more efficiently identified candidates for validation.
デジタル研究開発
Five Markers of AI Readiness in R&D
AI-powered solutions hold so much potential for faster scientific innovation, but there are key milestones organizations must achieve before they can move beyond the pilot phase. These five markers are the cornerstones of AI readiness.
.avif)
エマージング・サイエンス
Point-of-care testing: faster diagnosis, easier access to care
Point-of-care testing goes beyond pandemic-era viral infection tests to bring faster diagnostics for infectious diseases, chronic conditions, cancer, and more.